Drug recall D-0816-2026
Product
Clindamycin Phosphate in 0.9% Sodium Chloride Injection, 600 mg per 50 mL (12 mg/mL), 50 mL Single-Dose GALAXY Container, Rx only, Sterile Nonpyrogenic, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, NDC 0338-9549-50.
Reason for recall
CGMP Deviations
Lots and codes
Lot # NC193689, Exp Date: 10/16/2027.
Recall details
- Recalling firm
- Baxter Healthcare Corporation, Deerfield, IL
- Quantity
- N/A
- Distribution
- US Nationwide; Puerto Rico; and Chile.
- Type
- Voluntary: Firm initiated
- Recall initiated
- August 6, 2026
Related products
- Clindamycin phosphate – drug information
- NDC 0338-9553 Clindamycin phosphate · Clindamycin Phosphate 900 mg/50mL · Baxter Healthcare Company
- NDC 0338-9549 Clindamycin phosphate · Clindamycin Phosphate 600 mg/50mL · Baxter Healthcare Company
- NDC 0338-9545 Clindamycin phosphate · Clindamycin Phosphate 300 mg/50mL · Baxter Healthcare Company